FDA Approves First Drug Patch for Depression: "The Food and Drug Administration today approved Emsam (selegiline), the first skin (transdermal) patch for use in treating major depression. The once a day patch works by delivering selegiline, a monoamine oxidase inhibitor or MAOI, through the skin and into the bloodstream. At its lowest strength, Emsam can be used without the dietary restrictions that are needed for all oral MAO inhibitors that are approved for treating major depression. "
Tuesday, February 28, 2006
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment